{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:17:22Z","timestamp":1788553042278,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,9,3]],"date-time":"2027-09-03T00:00:00Z","timestamp":1819929600000},"content-version":"am","delay-in-days":306,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Government of Japan Ministry of Health Labour and Welfare","doi-asserted-by":"publisher","award":["23AA2003"],"award-info":[{"award-number":["23AA2003"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jamda.2026.106481","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:58:31Z","timestamp":1788440311000},"page":"106481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment Duration of Cholinesterase Inhibitor Formulations in Alzheimer's Disease"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1265-6835","authenticated-orcid":false,"given":"So","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Sasabuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Yamana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahide","family":"Kohro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Yasunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2026.106481_bib2","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/alz.13016","article-title":"2023 Alzheimer's disease facts and figures","volume":"19","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jamda.2026.106481_bib3","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/jama.2019.4782","article-title":"Diagnosis and management of dementia: review","volume":"322","author":"Arvanitakis","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2026.106481_bib4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1001\/jamainternmed.2023.8522","article-title":"Dementia prevention and treatment: a narrative review","volume":"184","author":"Reuben","year":"2024","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jamda.2026.106481_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1586\/ern.11.178","article-title":"Impact of transdermal drug delivery on treatment adherence in patients with Alzheimer's disease","volume":"12","author":"Molinuevo","year":"2012","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.jamda.2026.106481_bib6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/ijnp\/pyx012","article-title":"Discontinuation, efficacy, and safety of cholinesterase inhibitors for Alzheimer's disease: a meta-analysis and meta-regression of 43 randomized clinical trials enrolling 16 106 patients","volume":"20","author":"Blanco-Silvente","year":"2017","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.jamda.2026.106481_bib7","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/0897190017710524","article-title":"Medication adherence in older patients with dementia: a systematic literature review","volume":"31","author":"El-Saifi","year":"2018","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.jamda.2026.106481_bib8","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s12272-014-0500-8","article-title":"Drug persistence of cholinesterase inhibitors for patients with dementia of Alzheimer type in Korea","volume":"38","author":"Ahn","year":"2015","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.jamda.2026.106481_bib9","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00228-013-1483-y","article-title":"A population-based study of dosing and persistence with anti-dementia medications","volume":"69","author":"Brewer","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jamda.2026.106481_bib10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2165\/11318010-000000000-00000","article-title":"Predictive factors of discontinuation and switch of cholinesterase inhibitors in community-dwelling patients with Alzheimer's disease: a 2-year prospective, multicentre, cohort study","volume":"24","author":"Gardette","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jamda.2026.106481_bib11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2165\/00002512-200926050-00004","article-title":"Persistence with cholinesterase inhibitor therapy for dementia: an observational administrative health database study","volume":"26","author":"Herrmann","year":"2009","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jamda.2026.106481_bib12","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2165\/11538230-000000000-00000","article-title":"Discontinuation of cholinesterase inhibitor treatment and determinants thereof in the Netherlands: a retrospective cohort study","volume":"27","author":"Kr\u00f6ger","year":"2010","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jamda.2026.106481_bib13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000345279","article-title":"Persistence of cholinesterase inhibitor treatment in dementia: insights from a naturalistic study","volume":"3","author":"Olazar\u00e1n","year":"2013","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"10.1016\/j.jamda.2026.106481_bib14","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1212\/WNL.0b013e31824d5773","article-title":"Effect of treatment gaps in elderly patients with dementia treated with cholinesterase inhibitors","volume":"78","author":"Pariente","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2026.106481_bib15","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1017\/S031716710001492X","article-title":"Less education predicts anticholinesterase discontinuation in dementia patients","volume":"40","author":"Saleh","year":"2013","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.jamda.2026.106481_bib16","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/YIC.0000000000000032","article-title":"Antidementia drug use among community-dwelling individuals with Alzheimer's disease in Finland: a nationwide register-based study","volume":"29","author":"Taipale","year":"2014","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.jamda.2026.106481_bib17","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1017\/S1041610208007011","article-title":"Discontinuation of donepezil for the treatment of Alzheimer's disease in geriatric practice","volume":"20","author":"Umegaki","year":"2008","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2026.106481_bib18","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1185\/03007995.2010.493788","article-title":"Predictors of adherence among Alzheimer's disease patients receiving oral therapy","volume":"26","author":"Borah","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jamda.2026.106481_bib19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/WAD.0000000000000006","article-title":"Medication adherence in patients with dementia: an Austrian cohort study","volume":"28","author":"Haider","year":"2014","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.jamda.2026.106481_bib20","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1741-6612.2011.00564.x","article-title":"Adherence, persistence, and continuation with cholinesterase inhibitors in Alzheimer's disease","volume":"31","author":"Le Couteur","year":"2012","journal-title":"Australas J Ageing"},{"key":"10.1016\/j.jamda.2026.106481_bib21","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/gps.3778","article-title":"Risk factors for medication nonadherence in older adults with cognitive impairment who live alone","volume":"27","author":"Thiruchselvam","year":"2012","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2026.106481_bib22","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/gps.1411","article-title":"Discontinuation of rivastigmine in routine clinical practice","volume":"20","author":"Frankfort","year":"2005","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2026.106481_bib23","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/archneur.56.6.735-a","article-title":"Do we have drugs for dementia? No","volume":"56","author":"Pryse-Phillips","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jamda.2026.106481_bib24","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(04)16499-4","article-title":"AD2000 Collaborative Group. Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial","volume":"363","author":"Courtney","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jamda.2026.106481_bib25","first-page":"CD005593","article-title":"Cholinesterase inhibitors for Alzheimer's disease","volume":"2006","author":"Birks","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jamda.2026.106481_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h869","article-title":"The challenge of overdiagnosis begins with its definition","volume":"350","author":"Carter","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2026.106481_bib28","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/j.1532-5415.2007.01377.x","article-title":"A population-based study of cholinesterase inhibitor use for dementia","volume":"55","author":"Herrmann","year":"2007","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2026.106481_bib29","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0140-6736(11)60828-3","article-title":"Japanese universal health coverage: evolution, achievements, and challenges","volume":"378","author":"Ikegami","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jamda.2026.106481_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.37737\/ace.24011","article-title":"Updated information on NDB","volume":"6","author":"Yasunaga","year":"2024","journal-title":"Ann Clin Epidemiol"},{"key":"10.1016\/j.jamda.2026.106481_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.37737\/ace.24001","article-title":"Services in public long-term care insurance in Japan","volume":"6","author":"Konishi","year":"2023","journal-title":"Ann Clin Epidemiol"},{"key":"10.1016\/j.jamda.2026.106481_bib32","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1447-0594.2011.00828.x","article-title":"Both conventional indices of cognitive function and frailty predict levels of care required in a long-term care insurance program for memory clinic patients in Japan","volume":"12","author":"Takechi","year":"2012","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.jamda.2026.106481_bib33","first-page":"316","article-title":"Current status and challenges of functional differentiation of facility- and residence-based services from the perspective of user characteristics","volume":"43","author":"Kawagoe","year":"2008","journal-title":"Shakai Hosho Kenkyu"},{"key":"10.1016\/j.jamda.2026.106481_bib34","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/ggi.13777","article-title":"Correlation between the Barthel Index and care need levels in the Japanese long-term care insurance system","volume":"19","author":"Matsuda","year":"2019","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.jamda.2026.106481_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101528","article-title":"Association between comprehensive geriatric assessment and polypharmacy at discharge in patients with ischaemic stroke: a nationwide, retrospective, cohort study","volume":"50","author":"Hosoi","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jamda.2026.106481_bib36","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.jamda.2026.106481_bib37","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0140-6736(18)30668-8","article-title":"Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care settings using electronic hospital records: an observational study","volume":"391","author":"Gilbert","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jamda.2026.106481_bib38","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1185\/030079906X89685","article-title":"Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease","volume":"22","author":"Bullock","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jamda.2026.106481_bib39","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2165\/00002512-200320060-00003","article-title":"Drug interactions with cholinesterase inhibitors","volume":"20","author":"Defilippi","year":"2003","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jamda.2026.106481_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.archger.2024.105465","article-title":"Global and regional prevalence of polypharmacy and related factors, 1997-2022: an umbrella review","volume":"124","author":"Kim","year":"2024","journal-title":"Arch Gerontol Geriatr"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861026003713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861026003713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:08:38Z","timestamp":1788552518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861026003713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1525861026003713"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2026.106481","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment Duration of Cholinesterase Inhibitor Formulations in Alzheimer's Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2026.106481","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Post-Acute and Long-Term Care Medical Association.","name":"copyright","label":"Copyright"}],"article-number":"106481"}}